Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Join SI Premium – FREE
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.31), $0.11 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- Oura said to be seeking up to $3 billion in IPO
- UL Solutions launches retail supply chain software platform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
